0

Journal Articles

in Osteoporosis/Metabolic Bone Disease
 1-20 of 186 Articles
JAMA Internal Medicine | 
Invited Commentary |  April 22, 2013
Are Calcium Supplements Harmful to Cardiovascular Disease?:  Comment on “ Dietary and Supplemental Calcium Intake and Cardiovascular Diseases Mortality: The National Institutes of Health–AARP Diet and Health Study”
Susanna C. Larsson, PhD
JAMA Intern Med. 2013;173(8):647-648. doi:10.1001/jamainternmed.2013.3769.
JAMA Ophthalmology | 
Small Case Series |  February 01, 2013
Squamous Metaplasia of the Conjunctiva:  A Previously Unrecognized Adverse Effect of Risedronate Sodium
Ivayla I. Geneva, BA; Ralph C. Eagle, MD; Ann Barker-Griffith, MD, FRCSC; et al.
JAMA Ophthalmol. 2013;131(2):249-251. doi:10.1001/jamaophthalmol.2013.578.
JAMA Internal Medicine | 
Editor's Correspondence |  January 14, 2013
Are Bisphosphonates Associated With an Increased Risk of Atypical Femoral Fractures as a Class?
Michael Pazianas, MD
JAMA Intern Med. 2013;173(1):79-80. doi:10.1001/2013.jamainternmed.753.
JAMA | 
Health Agencies Update |  July 25, 2012
HIV and Bone Mass
Bridget M. Kuehn
JAMA. 2012;308(4):331. doi:10.1001/jama.2012.8437.
JAMA | 
Viewpoint |  June 27, 2012
Bone Density Screening Intervals for Osteoporosis:  One Size Does Not Fit All
Elaine W. Yu, MD; Joel S. Finkelstein, MD
JAMA. 2012;307(24):2591-2592. doi:10.1001/jama.2012.6977.
JAMA Internal Medicine | 
Original Investigation |  June 25, 2012
Increasing Occurrence of Atypical Femoral Fractures Associated With Bisphosphonate Use
Raphael P. H. Meier, MD; Thomas V. Perneger, MD; Richard Stern, MD; et al.
Arch Intern Med. 2012;172(12):930-936. doi:10.1001/archinternmed.2012.1796.
JAMA Internal Medicine | 
Invited Commentary |  June 25, 2012
Atypical Femoral Fracture Risk in Patients Treated With Bisphosphonates:  Comment on “Increasing Occurrence of Atypical Femoral Fractures Associated With Bisphosphonate Use”
Douglas C. Bauer, MD
Arch Intern Med. 2012;172(12):936-937. doi:10.1001/archinternmed.2012.1827.
JAMA Internal Medicine | 
Editorial |  March 26, 2012
Does Motivational Interviewing Improve Outcomes?
Seth A. Berkowitz, MD; Kirsten L. Johansen, MD
Arch Intern Med. 2012;172(6):463-464. doi:10.1001/archinternmed.2012.155.
JAMA Internal Medicine | 
Original Investigation |  March 26, 2012 FREE
Osteoporosis Telephonic Intervention to Improve Medication Regimen Adherence:  A Large, Pragmatic, Randomized Controlled Trial
Daniel H. Solomon, MD, MPH; Maura D. Iversen, DSc; Jerry Avorn, MD; et al.
Arch Intern Med. 2012;172(6):477-483. doi:10.1001/archinternmed.2011.1977.
INCLUDES: , Supplemental Content
JAMA Pediatrics | 
Review Article |  March 01, 2012 FREE
Environmental Factors in Tiny Tim's Near-Fatal Illness
Russell W. Chesney, MD
Arch Pediatr Adolesc Med. 2012;166(3):271-275. doi:10.1001/archpediatrics.2011.852.
JAMA | 
Research Letters |  January 18, 2012 FREE
Screening for Osteoporosis in Men Receiving Androgen Deprivation Therapy
Shabbir M. H. Alibhai, MD, MSc; Lingsong Yun, MSc; Angela M. Cheung, MD, PhD; et al.
JAMA. 2012;307(3):255-256. doi:10.1001/jama.2011.2022.
JAMA Internal Medicine | 
Research Letters |  November 14, 2011 FREE
“Top 5” Lists Top $5 Billion
Minal S. Kale, MD; Tara F. Bishop, MD, MPH; Alex D. Federman, MD, MPH; et al.
Arch Intern Med. 2011;171(20):1858-1859. doi:10.1001/archinternmed.2011.501.
INCLUDES: , Supplemental Content
JAMA Internal Medicine | 
Invited Commentary |  October 10, 2011
FRAX, Falls, and Fracture Prediction: Predicting the Future:  Comment on “ ‘Timed Up and Go’ Test and Bone Mineral Density Measurement for Fracture Prediction”
Douglas C. Bauer, MD
Arch Intern Med. 2011;171(18):1661-1662. doi:10.1001/archinternmed.2011.495.
JAMA Internal Medicine | 
Original Investigation |  August 09, 2011 FREE
Soy Isoflavones in the Prevention of Menopausal Bone Loss and Menopausal Symptoms:  A Randomized, Double-blind Trial
Silvina Levis, MD; Nancy Strickman-Stein, PhD; Parvin Ganjei-Azar, MD; et al.
Arch Intern Med. 2011;171(15):1363-1369. doi:10.1001/archinternmed.2011.330.
JAMA Internal Medicine | 
Invited Commentary |  August 08, 2011
Soy Isoflavones for Prevention of Menopausal Bone Loss and Vasomotor Symptoms:  Comment on “Soy Isoflavones in the Prevention of Menopausal Bone Loss and Menopausal Symptoms”
Katherine M. Newton, PhD; Deborah Grady, MD, MPH
Arch Intern Med. 2011;171(15):1369-1370. doi:10.1001/archinternmed.2011.331.
JAMA Pediatrics | 
Commentary |  April 01, 2011
Skeleton of a Century:  American Journal of Diseases of Children and Rickets in the 1930s
Walton O. Schalick, MD, PhD
Arch Pediatr Adolesc Med. 2011;165(4):291-293. doi:10.1001/archpediatrics.2011.25.
JAMA Neurology | 
Original Contribution |  March 01, 2011 FREE
High Prevalence of Hypovitaminosis D Status in Patients With Early Parkinson Disease
Marian L. Evatt, MD, MS; Mahlon R. DeLong, MD; Meena Kumari, MD; et al.
Arch Neurol. 2011;68(3):314-319. doi:10.1001/archneurol.2011.30.
JAMA | 
Editorial |  February 23, 2011
Is Nitroglycerin a Novel and Inexpensive Treatment for Osteoporosis?
Sundeep Khosla, MD
JAMA. 2011;305(8):826-827. doi:10.1001/jama.2011.191.
JAMA | 
Preliminary Communication |  February 23, 2011 FREE
Effect of Nitroglycerin Ointment on Bone Density and Strength in Postmenopausal Women:  A Randomized Trial
Sophie A. Jamal, MD, PhD; Celeste J. Hamilton, MSc; Richard Eastell, MD; et al.
JAMA. 2011;305(8):800-807. doi:10.1001/jama.2011.176.
INCLUDES: , Supplemental Content
JAMA Internal Medicine | 
Research Letters |  November 22, 2010 FREE
Predicting Hip and Major Osteoporotic Fractures Using Administrative Data
Huifeng Yun, MD, MSc; Elizabeth Delzell, ScD; Kristine E. Ensrud, MD, MPH; et al.
Arch Intern Med. 2010;170(21):1940-1942. doi:10.1001/archinternmed.2010.410.

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA Internal Medicine
Invited Commentary  |  February 4, 2013
Are Calcium Supplements Harmful to Cardiovascular Disease?:  Comment on “ Dietary and Supplemental Calcium Intake and Cardiovascular Diseases Mortality: The National Institutes of Health–AARP Diet and Health Study”
Susanna C. Larsson, PhD
JAMA Ophthalmology
Small Case Series  |  Feb 2013
Squamous Metaplasia of the Conjunctiva:  A Previously Unrecognized Adverse Effect of Risedronate Sodium
Ivayla I. Geneva, BA; Ralph C. Eagle, MD; Ann Barker-Griffith, MD, FRCSC; et al.
JAMA Internal Medicine
Editor's Correspondence  |  Jan 14, 2013
Are Bisphosphonates Associated With an Increased Risk of Atypical Femoral Fractures as a Class?
Michael Pazianas, MD
JAMA
Health Agencies Update  |  July 25, 2012
HIV and Bone Mass
Bridget M. Kuehn
© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems